Clinical trial
A Prospective, Multicenter, Single-arm Clinical Study of NovoClasp Transcatheter Mitral Valve Clip and Steerable Guide Catheter for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation (DMR)
NCT06021509 is registered in ClinicalTrials.gov with Enlight Medical Technologies (Shanghai) Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Single-arm Clinical Study of NovoClasp Transcatheter Mitral Valve Clip and Steerable Guide Catheter for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation (DMR)
- Lead sponsor
- Enlight Medical Technologies (Shanghai) Co., Ltd
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- May 15, 2022
- Completion date
- June 25, 2028
- Enrollment
- 102 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
degenerative mitral valve disease